Step one shows a single tumour cell: Lu-177 DOTATATE leaves the capillary, binds the seven-transmembrane SSTR2, is internalised through a clathrin-coated pit, the receptor recycles and Lu-177 stays in the lysosome. Step two shows tissue at true scale: β tracks run across tens of cells and reach cells without receptors. Step three shows glomerular filtration and megalin-mediated reabsorption in the proximal tubule, compared with lysine-arginine.

Continuous stream · no seeking

Lu-177 DOTATATE binds SSTR2, is internalised and stays in the lysosome; β⁻ travels tens of cell diameters and irradiates neighbours too; lysine-arginine protects the kidney by reducing megalin-mediated reabsorption.

Source: book 26.4 (EANM); SSTR2 internalisation Reubi 2003 (Endocr Rev), Cescato 2006 (J Nucl Med); megalin-mediated reabsorption de Jong 2005, Vegt 2010 (J Nucl Med); β spectrum ENSDF, ranges NIST ESTAR (water). Timing and reabsorption probabilities representative.

How to use: a single click on the drawing pauses and resumes; in the third step ↑ ↓ or the buttons below switch the amino acid infusion on and off; ← → change steps.

Did this animation help you understand the topic?

Lu-177 DOTATATE: targeting and kidney protection · Open in Nuclear Medicine Explained ↗